# A Two-Part Study of BOTOX® Therapy for Ischemic Digits

> **NCT01309802** · PHASE2 · COMPLETED · sponsor: **Southern Illinois University** · enrollment: 48 (actual)

## Conditions studied

- Raynaud's Disease

## Interventions

- **DRUG:** onabotulinum toxin type-A

## Key facts

- **NCT ID:** NCT01309802
- **Lead sponsor:** Southern Illinois University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2016-05-19
- **Final completion:** 2016-07-13
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2019-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01309802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01309802, "A Two-Part Study of BOTOX® Therapy for Ischemic Digits". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01309802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*